Micrus Endovascular Company Profile
Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States. The Micrus product line is an endovascular system that enables a physician to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. We believe our products provide a safe and reliable alternative to more invasive neurosurgical procedures for treating aneurysms. Our proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. We also sell accessory devices and products used in conjunction with our microcoils. We rely extensively on our physician advisors to advise on our research and development efforts and to provide feedback on the clinical use of our products. Our advisors includes experts in interventional neuroradiology and cerebral vascular diseases. We regularly consult with our physician advisors regarding our research and development efforts, preclinical trials and clinical trials.
Location
821 Fox Lane
San Jose
CA
95131
United States of America
Contact
Phone: (408) 433-1400
Fax: (408) 433-1401
News Articles
No Advantage for Endovascular Stroke Treatment Over IV tPA
Results of the SYNTHESIS Expansion trial show no significant benefit for endovascular procedures over standard intravenous thrombolysis. Medscape Medical News
Ischemic Stroke: Does Endovascular Therapy Have a Role?
The continued use of endovascular therapy after t-PA is questioned by this study. Medscape Neurology
Endovascular Tx Does Not Top Clot-Buster (CME/CE)
(MedPage Today) -- Compared with intravenous thrombolytic therapy, endovascular therapy did not improve outcomes in patients with acute ischemic stroke, an Italian trial showed.
'Time Is Brain' Also Applies to Endovascular Tx (CME/CE)
HONOLULU (MedPage Today) -- A substudy of the IMS-III trial has quantitatively shown for the first time that delays in endovascular therapy for ischemic stroke are linearly correlated with worse outco...
Fenestrated Endovascular Graft Repairs Aortic Aneurysms
A customized endovascular stent graft can replace open invasive surgery in patients who have an abdominal aortic aneurysm that...
Endovascular Therapy Hopes Dashed Again (CME/CE)
(MedPage Today) -- For the second time in as many days, researchers' expectations that endovascular therapy would improve outcomes in patients with acute ischemic stroke have been dashed.
Endovascular aneurysm repair favored for very elderly
NEW YORK (Reuters Health) - For octogenarians and nonagenarians, endovascular repair (EVAR) carries a lower risk of death than open surgery for aortoiliac aneurysm (AA).
Endovascular Approaches to Free Floating Carotid Thrombi
Free floating thrombus in the carotid artery is a rare cause of ischemic stroke, with a diverse spectrum of pathologies. Which endovascular techniques should be used in this serious condition? Journ...
Drugs and Medications
None
PubMed Articles
Commentary: how do we decide when to stent and when to cut for mesenteric ischemia?
Endovascular Management of Mycotic Aortic Aneurysms.
Purpose: We report a single-center experience with the endovascular management of mycotic aortic aneurysms. Case reports: Four cases of mycotic aortic aneurysms are described; all treated with endovas...
Abstract Purpose: To examine the feasibility of an automated 2-dimensional (2D) to 3- dimensional (3D) image registration system to simplify the navigational challenges faced in complex endovascular a...
Chronic mesenteric ischemia: endovascular versus open revascularization.
Abstract To review 20 years of literature on chronic mesenteric ischemia (CMI), examining its complex clinical presentation and comparing open and endovascular treatment options. Methods: The PubMed a...
Clinical Trials
TX2® Low Profile TAA Endovascular Graft
The Zenith® TX2® Low Profile TAA Endovascular Graft study is a clinical trial approved by US FDA to evaluate the safety and effectiveness of the Zenith® TX2® Low Profile TAA Endovascul...
Post-Approval Study for the FLAIR Endovascular Stent Graft
The purpose of this study is to confirm the long-term safety and effectiveness of the FLAIR Endovascular Stent Graft for treatment of stenoses at the venous anastomosis of ePTFE or other s...
Endovascular Exclusion of Thoracic Aortic Aneurysms
The purpose of this study is to assess the role of descending thoracic aortic aneurysm exclusion using a novel endovascular prosthesis in high risk surgical patients.
Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm
To collect and analyze clinical follow-up data which can be used to assess the safety, efficacy, and durability of endovascular AAA repair with Zenith and Chuter-Gianturco stent-grafts.
Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis
This is a prospective, multi-center single arm registry to assess the use of the OmniWave Endovascular System in subjects presenting with either lower or upper extremity acute (symptoms ha...
Companies
Micrus Endovascular Corporation
Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventi...
Micrus Endovascular is a medical device company formed in June 1996 with its corporate headquarters in San Jose, California. Micrus Endovascular manufactures and markets both implantable and disposabl...
Patients with vascular conditions require flexible treatment options, including both traditional open vascular interventions and endovascular therapies. Current research indicates that surgeons use a...
Aptus Endosystems is a privately held medical technology company that has developed advanced technology for the endovascular treatment of aortic aneurysm disease. Founded in 2002,...
ev3 Inc. is a leading worldwide medical device company one hundred percent focused on catheter-based or endovascular technologies for the minimally invasive treatment of vascular disease and disorders...
More Information about "Micrus Endovascular" on BioPortfolio
We have published hundreds of Micrus Endovascular news stories on BioPortfolio along with dozens of Micrus Endovascular Clinical Trials and PubMed Articles about Micrus Endovascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Micrus Endovascular Companies in our database. You can also find out about relevant Micrus Endovascular Drugs and Medications on this site too.
